These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

725 related items for PubMed ID: 25797312

  • 1. Clinical experience of scoring criteria for Familial Hypercholesterolaemia (FH) genetic testing in Wales.
    Haralambos K, Whatley SD, Edwards R, Gingell R, Townsend D, Ashfield-Watt P, Lansberg P, Datta DB, McDowell IF.
    Atherosclerosis; 2015 May; 240(1):190-6. PubMed ID: 25797312
    [Abstract] [Full Text] [Related]

  • 2. Genetic analysis of familial hypercholesterolaemia in Western Australia.
    Hooper AJ, Nguyen LT, Burnett JR, Bates TR, Bell DA, Redgrave TG, Watts GF, van Bockxmeer FM.
    Atherosclerosis; 2012 Oct; 224(2):430-4. PubMed ID: 22883975
    [Abstract] [Full Text] [Related]

  • 3. Diagnosis and treatment of familial hypercholesterolaemia.
    Hovingh GK, Davidson MH, Kastelein JJ, O'Connor AM.
    Eur Heart J; 2013 Apr; 34(13):962-71. PubMed ID: 23416791
    [Abstract] [Full Text] [Related]

  • 4. Causative mutations and premature cardiovascular disease in patients with heterozygous familial hypercholesterolaemia.
    Rubba P, Gentile M, Marotta G, Iannuzzi A, Sodano M, De Simone B, Jossa F, Iannuzzo G, Giacobbe C, Di Taranto MD, Fortunato G.
    Eur J Prev Cardiol; 2017 Jul; 24(10):1051-1059. PubMed ID: 28353356
    [Abstract] [Full Text] [Related]

  • 5. Homozygous familial hypercholesterolaemia in Vietnam: Case series, genetics and cascade testing of families.
    Truong TH, Kim NT, Nguyen MNT, Pang J, Hooper AJ, Watts GF, Do DL.
    Atherosclerosis; 2018 Oct; 277():392-398. PubMed ID: 30270076
    [Abstract] [Full Text] [Related]

  • 6. Clinical characterization and mutation spectrum of German patients with familial hypercholesterolemia.
    Grenkowitz T, Kassner U, Wühle-Demuth M, Salewsky B, Rosada A, Zemojtel T, Hopfenmüller W, Isermann B, Borucki K, Heigl F, Laufs U, Wagner S, Kleber ME, Binner P, März W, Steinhagen-Thiessen E, Demuth I.
    Atherosclerosis; 2016 Oct; 253():88-93. PubMed ID: 27596133
    [Abstract] [Full Text] [Related]

  • 7. Next-generation-sequencing-based identification of familial hypercholesterolemia-related mutations in subjects with increased LDL-C levels in a latvian population.
    Radovica-Spalvina I, Latkovskis G, Silamikelis I, Fridmanis D, Elbere I, Ventins K, Ozola G, Erglis A, Klovins J.
    BMC Med Genet; 2015 Sep 28; 16():86. PubMed ID: 26415676
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Clinical features of familial hypercholesterolemia in Korea: Predictors of pathogenic mutations and coronary artery disease - A study supported by the Korean Society of Lipidology and Atherosclerosis.
    Shin DG, Han SM, Kim DI, Rhee MY, Lee BK, Ahn YK, Cho BR, Woo JT, Hur SH, Jeong JO, Jang Y, Lee JH, Lee SH.
    Atherosclerosis; 2015 Nov 28; 243(1):53-8. PubMed ID: 26343872
    [Abstract] [Full Text] [Related]

  • 11. Use of the denaturing gradient gel electrophoresis (DGGE) method for mutational screening of patients with familial hypercholesterolaemia (FH) and Familial defective apolipoprotein B100 (FDB).
    Azian M, Hapizah MN, Khalid BA, Khalid Y, Rosli A, Jamal R.
    Malays J Pathol; 2006 Jun 28; 28(1):7-15. PubMed ID: 17694954
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Genetic diagnosis of familial hypercholesterolaemia using a rapid biochip array assay for 40 common LDLR, APOB and PCSK9 mutations.
    Martin R, Latten M, Hart P, Murray H, Bailie DA, Crockard M, Lamont J, Fitzgerald P, Graham CA.
    Atherosclerosis; 2016 Nov 28; 254():8-13. PubMed ID: 27680772
    [Abstract] [Full Text] [Related]

  • 15. A novel type of familial hypercholesterolemia: double heterozygous mutations in LDL receptor and LDL receptor adaptor protein 1 gene.
    Tada H, Kawashiri MA, Ohtani R, Noguchi T, Nakanishi C, Konno T, Hayashi K, Nohara A, Inazu A, Kobayashi J, Mabuchi H, Yamagishi M.
    Atherosclerosis; 2011 Dec 28; 219(2):663-6. PubMed ID: 21872251
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Identification of a novel LDLR disease-causing variant using capture-based next-generation sequencing screening of familial hypercholesterolemia patients in Taiwan.
    Hsiung YC, Lin PC, Chen CS, Tung YC, Yang WS, Chen PL, Su TC.
    Atherosclerosis; 2018 Oct 28; 277():440-447. PubMed ID: 30270083
    [Abstract] [Full Text] [Related]

  • 18. Novel functional APOB mutations outside LDL-binding region causing familial hypercholesterolaemia.
    Alves AC, Etxebarria A, Soutar AK, Martin C, Bourbon M.
    Hum Mol Genet; 2014 Apr 01; 23(7):1817-28. PubMed ID: 24234650
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Cost-utility analysis of searching electronic health records and cascade testing to identify and diagnose familial hypercholesterolaemia in England and Wales.
    Crosland P, Maconachie R, Buckner S, McGuire H, Humphries SE, Qureshi N.
    Atherosclerosis; 2018 Aug 01; 275():80-87. PubMed ID: 29879685
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.